| Sexism and racism: Old-fashioned and modern prejudices. JK Swim, KJ Aikin, WS Hall, BA Hunter Journal of personality and social psychology 68 (2), 199, 1995 | 2456 | 1995 |
| Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs—summary of FDA survey research results KJ Aikin, JL Swasy, AC Braman | 175 | 2004 |
| Drug prevention in a community setting: A longitudinal study of the relative effectiveness of a three-year primary prevention program in Boys & Girls Clubs across the nation TL St. Pierre, DL Kaltreider, MM Mark, KJ Aikin American Journal of Community Psychology 20 (6), 673-706, 1992 | 99 | 1992 |
| Involving parents of high-risk youth in drug prevention: A three-year longitudinal study in Boys & Girls Clubs TLS Pierre, MM Mark, DL Kaltreider, KJ Aikin The Journal of Early Adolescence 17 (1), 21-50, 1997 | 83 | 1997 |
| A 27-month evaluation of a sexual activity prevention program in Boys & Girls Clubs across the nation TL St. Pierre, MM Mark, DL Kaltreider, KJ Aikin Family Relations, 69-77, 1995 | 83 | 1995 |
| An examination of the relative impact of assigned goals and self‐efficacy on personal goals and performance over time SB Button, JE Mathieu, KJ Aikin Journal of Applied Social Psychology 26 (12), 1084-1103, 1996 | 63 | 1996 |
| Correction of overstatement and omission in direct-to-consumer prescription drug advertising KJ Aikin, KR Betts, AC O'Donoghue, DJ Rupert, PK Lee, JB Amoozegar, ... Journal of Communication 65 (4), 596-618, 2015 | 43 | 2015 |
| Randomized trial of risk information formats in direct-to-consumer prescription drug advertisements KJ Aikin, AC O’Donoghue, JL Swasy, HW Sullivan Medical Decision Making 31 (6), E23-E33, 2011 | 40 | 2011 |
| Presenting efficacy information in direct-to-consumer prescription drug advertisements AC O’Donoghue, HW Sullivan, KJ Aikin, D Chowdhury, RR Moultrie, ... Patient Education and Counseling 95 (2), 271-280, 2014 | 37 | 2014 |
| Correction of misleading information in prescription drug television advertising: The roles of advertisement similarity and time delay KJ Aikin, BG Southwell, RS Paquin, DJ Rupert, AC O'Donoghue, KR Betts, ... Research in Social and Administrative Pharmacy 13 (2), 378-388, 2017 | 31 | 2017 |
| Direct-to-consumer advertising of prescription drugs and the patient–prescriber encounter: a systematic review JT DeFrank, ND Berkman, L Kahwati, K Cullen, KJ Aikin, HW Sullivan Health Communication 35 (6), 739-746, 2020 | 29 | 2020 |
| Communicating benefit and risk information in direct-to-consumer print advertisements: a randomized study HW Sullivan, AC O’Donoghue, KJ Aikin Therapeutic innovation & regulatory science 49 (4), 493-502, 2015 | 29 | 2015 |
| Prescription drug promotion from 2001-2014: data from the US food and drug administration HW Sullivan, KJ Aikin, E Chung-Davies, M Wade PLoS One 11 (5), e0155035, 2016 | 22 | 2016 |
| The “pharmacokinetics” of patient communications LA Morris, KJ Aikin Drug Information Journal 35 (2), 509-527, 2001 | 22 | 2001 |
| Patient and physician attitudes and behaviors associated with DTC promotion of prescription drugs KJ Aikin, JL Swasy, AC Braman US Department of Health and Human Services Food and Drug Administration …, 2004 | 21 | 2004 |
| Visual presentations of efficacy data in direct-to-consumer prescription drug print and television advertisements: A randomized study HW Sullivan, AC O’Donoghue, KJ Aikin, D Chowdhury, RR Moultrie, ... Patient education and counseling 99 (5), 790-799, 2016 | 20 | 2016 |
| Communicating risk information in direct-to-consumer prescription drug television ads: A content analysis HW Sullivan, KJ Aikin, J Poehlman Health Communication 34 (2), 212-219, 2019 | 19 | 2019 |
| Despite 2007 law requiring FDA hotline to be included in print drug ads, reporting of adverse events by consumers still low DT Du, J Goldsmith, KJ Aikin, WE Encinosa, C Nardinelli Health Affairs 31 (5), 1022-1029, 2012 | 19 | 2012 |
| Randomized study of placebo and framing information in direct-to-consumer print advertisements for prescription drugs AC O'Donoghue, HW Sullivan, KJ Aikin Annals of Behavioral Medicine 48 (3), 311-322, 2014 | 18 | 2014 |
| Serious and actionable risks, plus disclosure: Investigating an alternative approach for presenting risk information in prescription drug television advertisements KR Betts, V Boudewyns, KJ Aikin, C Squire, S Dolina, JJ Hayes, ... Research in Social and Administrative Pharmacy 14 (10), 951-963, 2018 | 17 | 2018 |
